TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Auna S.A. Class A ( (AUNA) ) just unveiled an update.
On November 20, 2025, Auna S.A. announced its financial results for the third quarter of 2025, highlighting a mixed performance across its operations in Peru, Colombia, and Mexico. While the company saw growth in Peru and Colombia, with increased revenues and profitability in local currencies, Mexico faced challenges with declining revenues and profitability due to legacy issues and system migrations. Despite these challenges, Auna maintained a stable leverage ratio and completed a significant debt refinancing, positioning itself for future growth and operational improvements.
The most recent analyst rating on (AUNA) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Auna S.A. Class A stock, see the AUNA Stock Forecast page.
Spark’s Take on AUNA Stock
According to Spark, TipRanks’ AI Analyst, AUNA is a Neutral.
Auna S.A. Class A’s overall score is driven by strong cash flow and profitability margins, but is negatively impacted by bearish technical indicators and high leverage. The earnings call provided a positive outlook with EBITDA growth, yet market challenges remain.
To see Spark’s full report on AUNA stock, click here.
More about Auna S.A. Class A
Auna S.A. is a leading healthcare platform operating in Latin America, with significant operations in Mexico, Peru, and Colombia. The company focuses on providing healthcare services and insurance, with a strong emphasis on oncology and hospital operations across these regions.
Average Trading Volume: 73,361
Technical Sentiment Signal: Sell
Current Market Cap: $364.1M
See more insights into AUNA stock on TipRanks’ Stock Analysis page.